Oral angiotensin-converting enzyme inhibitors for treatment of delayed inflammatory reaction to dermal hyaluronic acid fillers following COVID-19 vaccination-a model for inhibition of angiotensin II–induced cutaneous inflammation

• Girish Gilly Munavalli, MD, MHS, FACMS,
• Siri Knutsen-Larson, MD,
• Mary P. Lupo, MD,
• Roy G. Geronemus, MD

Affiliations

Girish Gilly Munavalli, MD, MHS, FACMS

Dermatology, Laser and Vein Specialists of the Carolinas, Charlotte, North Carolina; Department of Dermatology, the Wake Forest School of Medicine, Winston-Salem, North Carolina; Correspondence to: Girish Gilly Munavalli, MD, MHS, FACMS, 1918 Randolph Rd, Suite 550, Charlotte, NC 28207.

Siri Knutsen-Larson, MD

South Dakota Sanford School of Medicine, Vermillion, South Dakota

Mary P. Lupo, MD

Lupo Center for Aesthetic and General Dermatology, New Orleans, Louisiana

Roy G. Geronemus, MD

Laser and Skin Surgery Center of New York, New York, New York